Breast reconstruction following prophylactic or therapeutic mastectomy for breast cancer: Recommendations from an evidence-based provincial guideline

Canadian Journal of Plastic Surgery

Volumn 22, Issue 2, 2014, Pages 103-111

  Shea Budgell, Melissa ^a   Quan, May Lynn ^b   Mehling, Blair ^c   Temple Oberle, Claire ^b  

^a ALBERTA HEALTH SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Breast cancer; Breast reconstruction; Guideline; Mastectomy

Indexed keywords

EID: 84904512451     PISSN: 11952199     EISSN: None     Source Type: Journal    
DOI: 10.1177/229255031402200204     Document Type: Review

References (130)

1. National Comprehensive Cancer Network. Breast Cancer Clinical Practice Guidelines in Oncology Version 1.2012. (Accessed August 10, 2012).
2. Cancer Care Ontario. Program in Evidence-Based Care. Surgical Management of Early-Stage Invasive Breast Cancer. Practice Guideline Report #1-1 Version 2. 2003 (updated 2010). (Accessed August 10, 2012).
3. Canadian Partnership Against Cancer and Canadian Institute for Health Information. Breast Cancer Surgery in Canada, 2007-2008 to 2009-2010. (Accessed December 31, 2012).
4. CancerControl Alberta. Treatment Guidelines: Risk Reduction and Surveillance Strategies for Individuals at High Genetic Risk for Breast and Ovarian Cancer. The Provincial Breast Tumour Team and the Guideline Utilization Resource Unit. (Accessed August 10, 2012).
5. Horsman D, Wilson BJ, Avard D, et al; National Hereditary Cancer Task Force. Clinical management recommendations for surveillance and risk reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation. J Obstet Gynaecol Can 2007;29:45-60.
6. National Institute of Clinical Excellence, UK. Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. NICE clinical guideline 41. October 2006. (Accessed August 10, 2012).
7. National Comprehensive Cancer Network. Genetic/familial high risk assessment: Breast and ovarian. Practice Guidelines in Oncology version 1.2006. (Accessed August 10, 2012).
8. Chen CL, Liao MN, Chen SC, Chan PL, Chen SC. Body image and its predictors in breast cancer patients receiving surgery. Cancer Nurs 2012;35:E10-6.
9. Dunn LB, Cooper BA, Neuhaus J, et al. Identification of distinct depressive symptom trajectories in women following surgery for breast cancer. Health Psychol 2011;30:683-92.
10. Metcalfe KA, Semple J, Quan ML, et al. Changes in psychosocial functioning 1 year after mastectomy alone, delayed breast reconstruction, or immediate breast reconstruction. Ann Surg Oncol 2012;19:233-41.
11. Skrzypulec V, Tobor E, Drosdzol A, Nowosielski K. Biopsychosocial functioning of women after mastectomy. J Clin Nurs 2009;18:613-9.
12. Brandberg Y, Sandelin K, Erikson S, et al. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: A prospective 1-year follow-up study. J Clin Oncol 2008;26:3943-9.
13. Spyropoulou AC, Papageorgiou C, Markopoulos C, Christodoulou GN, Soldatos KR. Depressive symptomatology correlates with phantom breast syndrome in mastectomized women. Eur Arch Psychiatry Clin Neurosci 2008;258:165-70.
14. Schover LR. Sexuality and body image in younger women with breast cancer. J Natl Cancer Inst Monogr 1994;16:177-82.
15. Schain WS, Wellisch DK, Pasnau RO, Landsverk J. The sooner the better: A study of psychological factors in women undergoing immediate versus delayed breast reconstruction. Am J Psychiatry 1985;142:40-6.
16. Wellisch DK, Schain WS, Noone RB, Little JW III. Psychosocial correlates of immediate versus delayed reconstruction of the breast. Plast Reconstr Surg 1985;76:713-8.
17. Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer 2000;36:1938-43.
18. National Institute for Health and Clinical Excellence. How NICE clinical guidelines are developed: An overview for stakeholders, the public and the NHS, 4th edn. London: National Institute for Health and Clinical Excellence, 2009.
19. Cummings P, Rivara FP. Reviewing manuscripts for Archives of Pediatrics & Adolescent Medicine. Arch Pediatr Adolesc Med 2002;156:11-13.
20. AGREE Collaboration. Appraisal of guidelines for research and evaluation (AGREE) instrument. (Accessed November 15, 2009).
21. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. v1.2012. (Accessed August 13, 2012).
22. Aebi S, Davidson T, Gruber G, Castiglione M, on behalf of the ESMO Guidelines Working Group. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl 5):v9-v14.
23. New Zealand Guidelines Group. Surgery for early invasive breast cancer. In: New Zealand Guidelines Group. Management of Early Breast Cancer. Wellington: New Zealand Guidelines Group (NZGG) 2009:29-57.
24. Kaufmann M, Morrow M, Von MG, et al. Locoregional treatment of primary breast cancer: Consensus recommendations from an International Expert Panel. Cancer 2010;116:1184-91.
25. National Collaborating Centre for Cancer. Early and locally advanced breast cancer: Diagnosis and treatment (NICE clinical guideline; no. 80). London: National Institute for Health and Clinical Excellence (NICE) 2009:37.
26. Dawood S, Merajver SD, Viens P, et al. International expert panel on inflammatory breast cancer: Consensus statement for standardized diagnosis and treatment. Ann Oncol 2010;22:515-23.
27. Lee BT, Duggan MM, Keenan MT, et al. Massachusetts Board of Registration in Medicine Expert Panel on Immediate Implant-Based Breast Reconstruction following Mastectomy for Cancer. Commonwealth of Massachusetts Board of Registration in Medicine Expert Panel on immediate implant-based breast reconstruction following mastectomy for cancer: Executive summary. J Am Coll Surg 2011;213:800-5.
28. Nissen MJ, Swenson KK, Ritz LJ, Farrell JB, Sladek ML, Lally RM. Quality of life after breast carcinoma surgery: A comparison of three surgical procedures. Cancer 2001;91:1238-46.
29. Atisha D, Alderman AK, Lowery JC, Kuhn LE, Davis J, Wilkins EG. Prospective analysis of long-term psychosocial outcomes in breast reconstruction: Two-year postoperative results from the Michigan Breast Reconstruction Outcomes Study. Ann Surg 2008;247:1019-28.
30. Guyomard V, Leinster S, Wilkinson M. Systematic review of studies of patients' satisfaction with breast reconstruction after mastectomy. Breast 2007;16:547-67.
31. Xue DQ, Qian C, Yang L, Wang XF. Risk factors for surgical site infections after breast surgery: A systematic review and metaanalysis. Eur J Surg Oncol 2012;38:375-81.
32. Temple C, Cook EF, Ross DC, et al. Development of a Breast Reconstruction Satisfaction Questionnaire (BRECON): Dimensionality and clinical importance of breast symptoms, donor site issues, patient expectations, and relationships. J Surg Oncol 2010;101:209-16.
33. Dool JS. Reconstruction following mastectomy for stage I or stage II breast cancer-an epidemiologic study. Department of Community Health Sciences, University of Calgary. Master of Science Thesis. October 2005.
34. Gieni M, Avram R, Dickson L, et al. Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: A meta-analysis. Breast 2012;21:230-6.
35. Ceradini DJ, Levine JP. Breast cancer reconstruction: More than skin deep. Prim Psych 2008;72-80.
36. Clark L, Holcombe C, Hill J, et al. Sexual abuse in childhood and postoperative depression in women with breast cancer who opt for immediate reconstruction after mastectomy. Ann R Coll Surg Engl 2011;93:106-10.
37. Alderman AK, Hawley ST, Janz NK, et al. Racial and ethnic disparities in the use of postmastectomy breast reconstruction: Results from a population-based study. J Clin Oncol 2009;27:5325-30.
38. Joslyn SA. Patterns of care for immediate and early delayed breast reconstruction following mastectomy. Plast Reconstr Surg 2005;115:1289-96.
39. Elmore L, Myckatyn TM, Gao F, et al. Reconstruction patterns in a single institution cohort of women undergoing mastectomy for breast cancer. Ann Surg Oncol 2012;19:3223-9.
40. Platt J, Baxter N, Zhong T. Breast reconstruction after mastectomy for breast cancer. CMAJ 2011;183:2109-16.
41. Pezner RD, Lipsett JA, Vora NL, et al. Limited usefulness of observer-based cosmesis scales employed to evaluate patients treated conservatively for breast cancer. Int J Radiation Oncology Biol Phys 1985;11:1117-9.
42. Kroll SS, Evans GRD, Reece GP, et al. Comparison of resource costs between implant-based and TRAM flap breast reconstruction. Plast Reconstr Surg 1996;97:364-72.
43. Kroll SS, Sharma S, Koutz C, et al. Postoperative morphine requirements of free TRAM and DIEP flaps. Plast Reconstr Surg 2001;107:338-41.
44. Kroll SS, Baldwin B. A comparison of outcomes using three different methods of breast reconstruction. Plast Reconstr Surg 1992;90:455-62.
45. Clough KB, O'Donoghue JM, Fitoussi AD, et al. Prospective evaluation of late cosmetic results following breast reconstruction: II. TRAM flap reconstruction. Plast Reconstr Surg 2001;107:1710-6.
46. Clough KB, O'Donoghue JM, Fitoussi AD, et al. Prospective evaluation of late cosmetic results following breast reconstruction: I: Implant reconstruction. Plast Reconstr Surg 2001;107:1702-9.
47. Cordeiro PG, Pusic AL, Disa JJ, et al. Irradiation after immediate tissue expander/implant breast reconstruction: Outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg 2004;113:877-81.
48. Williams JK, Carlson GW, Bostwick III, et al. The effects of radiation treatment after TRAM flap breast reconstruction. Plast Reconstr Surg 1997;100:1153-60.
49. Blondeel PN, Vanderstraeten CG, Monstrey SJ, et al. The donor site morbidity of free DIEP flaps and free TRAM flaps for breast reconstruction. Br J Plast Surg 1997;50:322-30.
50. Blondeel PN. One hundred free DIEP flap breast reconstructions: A personal experience. Br J Plast Surg 1999;52:104-11.
51. Grotting JC. The free abdominoplasty flap for immediate breast reconstruction. Ann Plast Surg 1991;27:351-54.
52. Allen RJ, Treece P. Deep inferior epigastric perforator flap for breast reconstruction. Ann Plast Surg 1994;32:32-8.
53. Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: The BREAST-Q. Plast Reconstr Surg 2009;124:345-53.
54. Spear SL, Newman MK, Bedford MS, Schwartz KA, Cohen M, Schwartz JS. A retrospective analysis of outcomes using three common methods for immediate breast reconstruction. Plast Reconstr Surg 2008;122:340-7.
55. Eriksen C, Lindgren EN, Frisell J, Stark B. A prospective randomized study comparing two different expander approaches in implant-based breast reconstruction: One stage versus two stages. Plast Reconstr Surg 2012;130:254e-64e.
56. Winters ZE, Haviland J, Balta V, Benson J, Reece-Smith A, Betambeau N. Prospective Trial Management Group. Integration of patient-reported outcome measures with key clinical outcomes after immediate latissimus dorsi breast reconstruction and adjuvant treatment. Br J Surg 2013;100:240-51.
57. Petit JY, Gentilini O, Rotmensz N, et al. Oncological results of immediate breast reconstruction: Long term follow-up of a large series at a single institution. Breast Cancer Res Treat 2008;112:545-9.
58. Alberta Health Services. Provincial Breast Tumour Team. Adjuvant Radiation Therapy for Invasive Breast Cancer. (Accessed August 15, 2012).
59. Tran NV, Chang DW, Gupta A, et al. Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 2001;108:78-82.
60. Williams JK, Bostwick J III, Bried JT, Mackay G, Landry J, Benton J. TRAM flap breast reconstruction after radiation treatment. Ann Surg 1995;221:756-64; discussion 764-6.
61. Javaid M, Song F, Leinster S, Dickson MG, James NK. Radiation effects on the cosmetic outcomes of immediate and delayed autologous breast reconstruction: An argument about timing. J Plast Reconstr Aesthet Surg 2006;59:16-26.
62. Barry M, Kell MR. Radiotherapy and breast reconstruction: A meta-analysis. Breast Cancer Res Treat 2011;127:15-22.
63. Evans GR, Schusterman MA, Kroll SS, et al. Reconstruction and the radiated breast: Is there a role for implants? Plast Reconstr Surg 1995;96:1111-5; discussion 1116-8.
64. Kronowitz SJ, Robb GL. Radiation therapy and breast reconstruction: A critical review of the literature. Plast Reconstr Surg 2009;124:395-408.
65. Nava MB, Pennati AE, Lozza L, Spano A, Zambetti M, Catanuto G. Outcome of different timings of radiotherapy in implant-based breast reconstructions. Plast Reconstr Surg 2011;128:353-9.
66. McGuire K, Rosenberg AL, Showalter S, Brill KL, Copit S. Timing of sentinel lymph node biopsy and reconstruction for patients undergoing mastectomy. Ann Plast Surg 2007;59:359-63.
67. Schrenk P, Woelfl S, Bogner S, Moser F, Wayand W. The use of sentinel node biopsy in breast cancer patients undergoing skin sparing mastectomy and immediate autologous reconstruction. Plast Reconstr Surg 2005;116:1278-86.
68. Christante D, Pommier SJ, Diggs BS, et al. Using complications associated with postmastectomy radiation and immediate breast reconstruction to improve surgical decision making. Arch Surg 2010;145:873-8.
69. Mannu GS, Navi A, Morgan A, et al. Sentinel lymph node biopsy before mastectomy and immediate breast reconstruction may predict post-mastectomy radiotherapy, reduce delayed complications and improve the choice of reconstruction. Int J Surg 2012;10:259-64.
70. Brady B, Fant J, Jones R, et al. Sentinel lymph node biopsy followed by delayed mastectomy and reconstruction. Am J Surg 2003;185:114-7.
71. Wood BC, David LR, Defranzo AJ, et al. Impact of sentinel lymph node biopsy on immediate breast reconstruction after mastectomy. Am J Surg 2009;75:551-6; discussion 556-7.
72. Forouhi P, Dixon JM, Leonard RC, Chetty U. Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer. Br J Surg 1995;82:79-82.
73. Decker MR, Greenblatt DY, Havlena J, Wilke LG, Greenberg CC, Neuman HB. Impact of neoadjuvant chemotherapy on wound complications after breast surgery. Surgery 2012;152:382-8.
74. Donker M, Hage JJ, Woerdeman LA, Rutgers EJ, Sonke GS, Vrancken Peeters MJ. Surgical complications of skin sparing mastectomy and immediate prosthetic reconstruction after neoadjuvant chemotherapy for invasive breast cancer. Eur J Surg Oncol 2012;38:25-30.
75. Zhong T, Hofer SO, McCready DR, Jacks LM, Cook FE, Baxter N. A comparison of surgical complications between immediate breast reconstruction and mastectomy: The impact on delivery of chemotherapy-an analysis of 391 procedures. Ann Surg Oncol 2012;19:560-6.
76. Caffo O, Cazzolli D, Scalet A, et al. Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer. Breast Cancer Res Treat 2000;60:267-75.
77. Giacalone PL, Rathat G, Daures JP, Benos P, Azria D, Rouleau C. New concept for immediate breast reconstruction for invasive cancers: Feasibility, oncological safety and esthetic outcome of postneoadjuvant therapy immediate breast reconstruction versus delayed breast reconstruction: A prospective pilot study. Breast Cancer Res Treat 2010;122:439-51.
78. Mitchem J, Herrmann D, Margenthaler JA, Aft RL. Impact of neoadjuvant chemotherapy on rate of tissue expander/implant loss and progression to successful breast reconstruction following mastectomy. Am J Surg 2008;196:519-22.
79. Oh E, Chim H, Soltanian HT. The effects of neoadjuvant and adjuvant chemotherapy on the surgical outcomes of breast reconstruction. J Plast Reconstr Aesthet Surg 2012;65:e267-80.
80. Azzawi K, Ismail A, Earl H, Forouhi P, Malata CM. Influence of neoadjuvant chemotherapy on outcomes of immediate breast reconstruction. Plast Reconstr Surg 2010;126:1-11.
81. Vandeweyer E, Deraemaecker R, Nogaret JM, Hertens D. Immediate breast reconstruction with implants and adjuvant chemotherapy: A good option? Acta Chir Belg 2003;103:98-101.
82. Kontos M, Lewis RS, Lüchtenborg M, Holmberg L, Hamed H. Does immediate breast reconstruction using free flaps lead to delay in the administration of adjuvant chemotherapy for breast cancer? Eur J Surg Oncol 2010;36:745-9.
83. Cowen D, Gross E, Rouannet P, et al. Immediate post-mastectomy breast reconstruction followed by radiotherapy: Risk factors for complications. Breast Cancer Res Treat 2010;121:627-34.
84. Kulkarni AR, Katz S, Hamilton AS, Graff JJ, Alderman AK. Patterns of use and patient satisfaction with breast reconstruction among obese patients: Results from a population-based study. Plast Reconstr Surg 2012;130:263-70.
85. Lanitis S, Tekkis PP, Sgourakis G, Dimopoulos N, Al Mufti R, Hadjiminas DJ. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: A meta-analysis of observational studies. Ann Surg 2010;251:632-9.
86. Shen J, Ellenhorn J, Qian D, Kulber D, Aronowitz J. Skin-sparing mastectomy: A survey based approach to defining standard of care. Am J Surg 2008;74:902-5.
87. Petit JY, Veronesi U, Orecchia R, et al. The nipple-sparing mastectomy: Early results of a feasibility study of a new application of perioperative radiotherapy (ELIOT) in the treatment of breast cancer when mastectomy is indicated. Tumori 2003;89:288-91.
88. Wijayanayagam A, Kumar AS, Foster RD, Esserman LJ. Optimizing the total skin-sparing mastectomy. Arch Surg 2008;143:38-45; discussion 45.
89. Warren Peled A, Foster RD, Stover AC, et al. Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. Ann Surg Oncol 2012;19:3402-9.
90. Maxwell GP, Storm-Dickerson T, Whitworth P, Rubano C, Gabriel A. Advances in nipple-sparing mastectomy: Oncological safety and incision selection. Aesthet Surg J 2011;31:310-9.
91. Stolier AJ, Sullivan SK, Dellacroce FJ. Technical considerations in nipple-sparing mastectomy: 82 consecutive cases without necrosis. Ann Surg Oncol 2008;15:1341-7.
92. Voltura AM, Tsangaris TN, Rosson GD, et al. Nipple-sparing mastectomy: Critical assessment of 51 procedures and implications for selection criteria. Ann Surg Oncol 2008;15:3396-401.
93. Sacchini V, Pinotti JA, Barros AC, et al. Nipple-sparing mastectomy for breast cancer and risk reduction: Oncologic or technical problem? J Am Coll Surg 2006;203:704-14.
94. Kim JY, Davila AA, Persing S, et al. A meta-analysis of human acellular dermis and submuscular tissue expander breast reconstruction. Plast Reconstr Surg 2012;129:28-41.
95. Dell DD, Weaver C, Kozempel J, Barsevick A. Recovery after transverse rectus abdominis myocutaneous flap breast reconstruction surgery. Oncol Nurs Forum 2008;35:189-96.
96. Man LX, Selber JC, Serletti JM. Abdominal wall following free TRAM or DIEP flap reconstruction: A meta-analysis and critical review. Plast Reconstr Surg 2009;124:752-64.
97. Egeberg A, Rasmussen MK, Ahm Sørensen J. Comparing the donor-site morbidity using DIEP, SIEA or MS-TRAM flaps for breast reconstructive surgery: A meta-analysis. J Plast Reconstr Aesthet Surg 2012;65:1474-80.
98. Futter CM, Weiler-Mithoff E, Hagen S, et al. Do pre-operative abdominal exercises prevent post-operative donor site complications for women undergoing DIEP flap breast reconstruction? A twocentre, prospective randomised controlled trial. Br J Plast Surg 2003;56:674-83.
99. Scuderi N, Alfano C, Campus GV, et al. Multicenter study on breast reconstruction outcome using Becker implants. Aesthetic Plast Surg 2011;35:66-72.
100. Barnsley GP, Sigurdson LJ, Barnsley SE. Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: A meta-analysis of randomized controlled trials. Plast Reconstr Surg 2006;117:2182-90.
101. U. S. Food and Drug Administration. Anaplastic large cell lymphoma (ALCL) in women with breast implants: Preliminary FDA findings and analyses. (Accessed September 13, 2012).
102. Eaves FF, Haeck PC, Rohrich RJ. Breast implants and anaplastic large cell lymphoma: Using science to guide our patients and plastic surgeons worldwide. Plast Reconstr Surg 2011;127:2501-3.
103. American Society of Plastic Surgeons. Important Health News on Breast Implants. (Accessed September 13, 2012).
104. Sim YT, Litherland JC. The use of imaging in patients post breast reconstruction. Clin Radiol 2012;67:128-33.
105. Barnsley GP, Grunfeld E, Coyle D, Paszat L. Surveillance mammography following the treatment of primary breast cancer with breast reconstruction: A systematic review. Plast Reconstr Surg 2007;120:1125-32.
106. Zakhireh J, Fowble B, Esserman LJ. Application of screening principles to the reconstructed breast. J Clin Oncol 2010;28:173-80.
107. Jansen LA, Macadam SA. The use of AlloDerm in postmastectomy alloplastic breast reconstruction: Part I. A systematic review. Plast Reconstr Surg 2011;127:2232-44.
108. Jansen LA, Macadam SA. The use of AlloDerm in postmastectomy alloplastic breast reconstruction: Part II. A cost analysis. Plast Reconstr Surg 2011;127:2245-54.
109. Vardanian AJ, Clayton JL, Roostaeian J, et al. Comparison of implant-based immediate breast reconstruction with and without acellular dermal matrix. Plastic Reconstr Surg 2011;128:403-10e.
110. Ho G, Nguyen TJ, Shahabi A, Hwang BH, Chan LS, Wong AK. A systematic review and meta-analysis of complications associated with acellular dermal matrix-assisted breast reconstruction. Ann Plast Surg 2012;68:346-56.
111. Hoppe IC, Yueh JH, Wei CH, Ahuja NK, Patel PP, Datiashvili RO. Complications following expander/implant breast reconstruction utilizing acellular dermal matrix: A systematic review and metaanalysis. Eplasty 2011;11:e40.
112. Salzberg CA. Focus on technique: One-stage implant-based breast reconstruction. Plast Reconstr Surg 2012;130:95S-103S.
113. Kim JY, Connor CM. Focus on technique: Two-stage implant-based breast reconstruction. Plast Reconstr Surg 2012;140:104S-15S.
114. Colwell AS, Damjanovic B, Zahedi B, Medford-Davis L, Hertl C, Austen WG Jr. Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: Indications, complications, trends, and costs. Plast Reconstr Surg 2011;128:1170-78.
115. Cordeiro PG, McKarthy CM. A single surgeon's 12-year experience with tissue expander/implant basted breast reconstruction: Part I. A prospective analysis of early complications. Plast Reconstr Surg 2006;118:8225-831.
116. Cordeiro PG, McCarthy CM. A single surgeon's 12-year experience with tissue expander/implant bresast reconstruction: Part II. An analysis of long-term complications, aesthetic outcomes, and patient satisfaction. Plast Recosntr Surg 2006;118-832-39.
117. Handel N, Cordray Y, Gutierrez J, Jensen JA. A long-term study of outcomes, complications, and patient satisfaction with breast implants. Plast Reconstr Surg 2006;117:757-67; discussion 768-72.
118. McCarthy CM, Lee CN, Halvorson EG, et al. The use of acellular dermal matrices in two-stage expander/implant reconstruction: A multicenter, blinded, randomized controlled trial. Plast Reconstr Surg 2012;130(5 Suppl 2):57S-66S.
119. Preminger BA, McCarthy CM, Hu QY, Mehrara BJ, Disa JJ. The influence of AlloDerm on expander dynamices and complications in the setting of immediate tissue expander/implant reconstruction. Ann Plast Surg 2008;60:510-3.
120. Venturi ML, Mesbahi AN, Boehmler JH IV, Marrogi AJ. Evaluating sterile human acellular dermal matrix in immediate expander-based breast reconstruction: A multicenter, prospective, cohort study. Plast Reconstr Surg 2013;131:9e-18e.
121. Sbitany H, Sandeen SN, Amalfi AN, Davenport MS, Langstein HN. Acellular dermis-assisted prosthetic breast reconstruction versus complete submuscular coverage: A head-to-head comparison of outcomes. Plast Reconstr Surg 2009;124:1735-40.
122. Clinical Trials.gov. One-stage breast reconstruction using dermal matrix/Implant versus two-stage expander/implant procedure (AllodermRCT). (Accessed February 26, 2013).
123. Sarfati I, Ihrai T, Duvernay A, Nos C, Clough K. [Autologous fat grafting to the postmastectomy irradiated chest wall prior to breast implant reconstruction: A series of 68 patients.] Ann Chir Plast Esthet 2012;S0294-1260.
124. Seth AK, Hirsch EM, Kim JY, Fine NA. Long-term outcomes following fat grafting in prosthetic breast reconstruction: A comparative analysis. Plast Reconstr Surg 2012;130:984-90.
125. Mestak O, Zimovjanová M. Breast reconstruction by autologous fat transfer. Rozhl Chir 2012;91:373-7.
126. de Blacam C, Momoh AO, Colakoglu S, Tobias AM, Lee BT. Evaluation of clinical outcomes and aesthetic results after autologous fat grafting for contour deformities of the reconstructed breast. Plast Reconstr Surg 2011;128:411e-418e.
127. Losken A, Pinell XA, Sikoro K, Yezhelyev MV, Anderson E, Carlson GW. Autologous fat grafting in secondary breast reconstruction. Ann Plast Surg 2011;66:518-22.
128. Pérez-Cano R, Vranckx JJ, Lasso JM, et al. Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial. Eur J Surg Oncol 2012;38:382-9.
129. Alderman AK, Kuhn LE, Lowery JC, et al. Does patient satisfaction with breast reconstruction change over time? Two-year results of the Michigan Breast Reconstruction Outcomes Study. J Am Coll Surg 2007;204:7-12.
130. Cigna E, Ribuffo D, Sorvillo V, et al. Secondary lipofilling after breast reconstruction with implants. Eur Rev Med Pharmacol Sci 2012;16:1729-34.